Badanie kliniczne nad skutecznością EP262 u dorosłych z przewlekłą pokrzywką samoistną

Chronic Spontaneous Urticaria (CSU) is a condition where red, itchy welts appear on the skin without a known cause. This study is focused on evaluating a new treatment called EP262, which is taken in the form of a capsule. The purpose of the study is to determine if EP262 is effective and safe for people with CSU. Participants in the study will receive either the EP262 capsule or a placebo, which looks like the treatment but does not contain the active substance.

The study will involve adult participants who have been diagnosed with CSU and are currently taking antihistamines, which are medications used to relieve allergy symptoms. The study will last for about six months, during which participants will take the study medication orally. Researchers will monitor changes in the intensity of itching and the number of hives, as well as any side effects that may occur. The study aims to provide more information on how well EP262 works compared to a placebo.